-
1
-
-
30344445931
-
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities
-
Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm. Bowel Dis. 2006; 12 (Suppl. 1): S3-9.
-
(2006)
Inflamm. Bowel Dis.
, vol.12
, Issue.1 SUPPL.
-
-
Hanauer, S.B.1
-
2
-
-
77954758654
-
The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models
-
Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat. Rev. Microbiol. 2010; 8: 564-77.
-
(2010)
Nat. Rev. Microbiol.
, vol.8
, pp. 564-577
-
-
Nell, S.1
Suerbaum, S.2
Josenhans, C.3
-
3
-
-
0032412057
-
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
-
Sellon RK, Tonkonogy S, Schultz M etal. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 1998; 66: 5224-31.
-
(1998)
Infect. Immun.
, vol.66
, pp. 5224-5231
-
-
Sellon, R.K.1
Tonkonogy, S.2
Schultz, M.3
-
4
-
-
0037425743
-
Gut flora in health and disease
-
Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-19.
-
(2003)
Lancet
, vol.361
, pp. 512-519
-
-
Guarner, F.1
Malagelada, J.R.2
-
6
-
-
0036151109
-
Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium
-
Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 2002; 70: 953-63.
-
(2002)
Infect. Immun.
, vol.70
, pp. 953-963
-
-
Hase, K.1
Eckmann, L.2
Leopard, J.D.3
Varki, N.4
Kagnoff, M.F.5
-
7
-
-
0034332193
-
The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations
-
Agerberth B, Charo J, Werr J etal. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96: 3086-93.
-
(2000)
Blood
, vol.96
, pp. 3086-3093
-
-
Agerberth, B.1
Charo, J.2
Werr, J.3
-
8
-
-
17044404692
-
Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens
-
Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 2005; 174: 4901-7.
-
(2005)
J. Immunol.
, vol.174
, pp. 4901-4907
-
-
Iimura, M.1
Gallo, R.L.2
Hase, K.3
Miyamoto, Y.4
Eckmann, L.5
Kagnoff, M.F.6
-
9
-
-
0034098916
-
Bactericidal activity of mammalian cathelicidin-derived peptides
-
Travis SM, Anderson NN, Forsyth WR etal. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 2000; 68: 2748-55.
-
(2000)
Infect. Immun.
, vol.68
, pp. 2748-2755
-
-
Travis, S.M.1
Anderson, N.N.2
Forsyth, W.R.3
-
10
-
-
33744493110
-
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
-
Schauber J, Rieger D, Weiler F etal. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol. 2006; 18: 615-21.
-
(2006)
Eur. J. Gastroenterol. Hepatol.
, vol.18
, pp. 615-621
-
-
Schauber, J.1
Rieger, D.2
Weiler, F.3
-
11
-
-
34249739104
-
A new role for cathelicidin in ulcerative colitis in mice
-
Tai EK, Wu WK, Wong HP, Lam EK, Yu L, Cho CH. A new role for cathelicidin in ulcerative colitis in mice. Exp. Biol. Med. (Maywood) 2007; 232: 799-808.
-
(2007)
Exp. Biol. Med. (Maywood)
, vol.232
, pp. 799-808
-
-
Tai, E.K.1
Wu, W.K.2
Wong, H.P.3
Lam, E.K.4
Yu, L.5
Cho, C.H.6
-
12
-
-
0034714188
-
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
-
Steidler L, Hans W, Schotte L etal. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1352-5.
-
(2000)
Science
, vol.289
, pp. 1352-1355
-
-
Steidler, L.1
Hans, W.2
Schotte, L.3
-
13
-
-
4143082646
-
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice
-
Vandenbroucke K, Hans W, Van Huysse J etal. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 2004; 127: 502-13.
-
(2004)
Gastroenterology
, vol.127
, pp. 502-513
-
-
Vandenbroucke, K.1
Hans, W.2
Van Huysse, J.3
-
14
-
-
33750496416
-
Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase
-
Han W, Mercenier A, Ait-Belgnaoui A etal. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel Dis. 2006; 12: 1044-52.
-
(2006)
Inflamm. Bowel Dis.
, vol.12
, pp. 1044-1052
-
-
Han, W.1
Mercenier, A.2
Ait-Belgnaoui, A.3
-
15
-
-
33646560334
-
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
-
Zocco MA, dal Verme LZ, Cremonini F etal. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 2006; 23: 1567-74.
-
(2006)
Aliment. Pharmacol. Ther.
, vol.23
, pp. 1567-1574
-
-
Zocco, M.A.1
dal Verme, L.Z.2
Cremonini, F.3
-
16
-
-
22744438084
-
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
-
Bibiloni R, Fedorak RN, Tannock GW etal. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 2005; 100: 1539-46.
-
(2005)
Am. J. Gastroenterol.
, vol.100
, pp. 1539-1546
-
-
Bibiloni, R.1
Fedorak, R.N.2
Tannock, G.W.3
-
17
-
-
72049119604
-
The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis
-
9 e1.
-
Sood A, Midha V, Makharia GK etal. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin. Gastroenterol. Hepatol. 2009; 7: 1202-9, 9 e1.
-
(2009)
Clin. Gastroenterol. Hepatol.
, vol.7
, pp. 1202-1209
-
-
Sood, A.1
Midha, V.2
Makharia, G.K.3
-
18
-
-
34447517430
-
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials
-
Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc. Nutr. Soc. 2007; 66: 307-15.
-
(2007)
Proc. Nutr. Soc.
, vol.66
, pp. 307-315
-
-
Hedin, C.1
Whelan, K.2
Lindsay, J.O.3
-
19
-
-
59249085585
-
Role of probiotic therapy in IBD
-
Isaacs K, Herfarth H. Role of probiotic therapy in IBD. Inflamm. Bowel Dis. 2008; 14: 1597-605.
-
(2008)
Inflamm. Bowel Dis.
, vol.14
, pp. 1597-1605
-
-
Isaacs, K.1
Herfarth, H.2
-
20
-
-
42349105761
-
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
-
Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 2008; 6: 349-62.
-
(2008)
Nat. Rev. Microbiol.
, vol.6
, pp. 349-362
-
-
Wells, J.M.1
Mercenier, A.2
-
21
-
-
0035464768
-
Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis
-
Le Loir Y, Nouaille S, Commissaire J, Bretigny L, Gruss A, Langella P. Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis. Appl. Environ. Microbiol. 2001; 67: 4119-27.
-
(2001)
Appl. Environ. Microbiol.
, vol.67
, pp. 4119-4127
-
-
Le Loir, Y.1
Nouaille, S.2
Commissaire, J.3
Bretigny, L.4
Gruss, A.5
Langella, P.6
-
22
-
-
79952929840
-
Gene-environment interactions in chronic inflammatory disease
-
Renz H, von Mutius E, Brandtzaeg P, Cookson WO, Autenrieth IB, Haller D. Gene-environment interactions in chronic inflammatory disease. Nat. Immunol. 2011; 12: 273-7.
-
(2011)
Nat. Immunol.
, vol.12
, pp. 273-277
-
-
Renz, H.1
von Mutius, E.2
Brandtzaeg, P.3
Cookson, W.O.4
Autenrieth, I.B.5
Haller, D.6
-
23
-
-
0024345189
-
High-frequency transformation, by electroporation, of lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media
-
Holo H, Nes IF. High-frequency transformation, by electroporation, of lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl. Environ. Microbiol. 1989; 55: 3119-23.
-
(1989)
Appl. Environ. Microbiol.
, vol.55
, pp. 3119-3123
-
-
Holo, H.1
Nes, I.F.2
-
24
-
-
0041887073
-
Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice
-
Liu ES, Ye YN, Shin VY etal. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 2003; 24: 1407-13.
-
(2003)
Carcinogenesis
, vol.24
, pp. 1407-1413
-
-
Liu, E.S.1
Ye, Y.N.2
Shin, V.Y.3
-
25
-
-
0027224059
-
Clinicopathologic study of dextran sulfate sodium experimental murine colitis
-
Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993; 69: 238-49.
-
(1993)
Lab. Invest.
, vol.69
, pp. 238-249
-
-
Cooper, H.S.1
Murthy, S.N.2
Shah, R.S.3
Sedergran, D.J.4
-
26
-
-
0026648674
-
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
-
Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992; 119: 493-501.
-
(1992)
J. Cell Biol.
, vol.119
, pp. 493-501
-
-
Gavrieli, Y.1
Sherman, Y.2
Ben-Sasson, S.A.3
-
27
-
-
0032836181
-
Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats
-
Guo X, Wang WP, Ko JK, Cho CH. Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology 1999; 117: 884-92.
-
(1999)
Gastroenterology
, vol.117
, pp. 884-892
-
-
Guo, X.1
Wang, W.P.2
Ko, J.K.3
Cho, C.H.4
-
28
-
-
0018384650
-
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
-
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979; 95: 351-8.
-
(1979)
Anal. Biochem.
, vol.95
, pp. 351-358
-
-
Ohkawa, H.1
Ohishi, N.2
Yagi, K.3
-
29
-
-
33847138191
-
Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats
-
Geier MS, Butler RN, Giffard PM, Howarth GS. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. Int. J. Food Microbiol. 2007; 114: 267-74.
-
(2007)
Int. J. Food Microbiol.
, vol.114
, pp. 267-274
-
-
Geier, M.S.1
Butler, R.N.2
Giffard, P.M.3
Howarth, G.S.4
-
30
-
-
0033860601
-
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial
-
Gionchetti P, Rizzello F, Venturi A etal. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-9.
-
(2000)
Gastroenterology
, vol.119
, pp. 305-309
-
-
Gionchetti, P.1
Rizzello, F.2
Venturi, A.3
-
31
-
-
9144254035
-
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
-
Mimura T, Rizzello F, Helwig U etal. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-14.
-
(2004)
Gut
, vol.53
, pp. 108-114
-
-
Mimura, T.1
Rizzello, F.2
Helwig, U.3
-
32
-
-
33646803802
-
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
-
Kuhbacher T, Ott SJ, Helwig U etal. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006; 55: 833-41.
-
(2006)
Gut
, vol.55
, pp. 833-841
-
-
Kuhbacher, T.1
Ott, S.J.2
Helwig, U.3
-
33
-
-
0035873326
-
Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system
-
Bu P, Keshavarzian A, Stone DD etal. Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J. Immunol. 2001; 166: 6399-403.
-
(2001)
J. Immunol.
, vol.166
, pp. 6399-6403
-
-
Bu, P.1
Keshavarzian, A.2
Stone, D.D.3
-
34
-
-
67449116312
-
Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity
-
Otte JM, Zdebik AE, Brand S etal. Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul. Pept. 2009; 156: 104-17.
-
(2009)
Regul. Pept.
, vol.156
, pp. 104-117
-
-
Otte, J.M.1
Zdebik, A.E.2
Brand, S.3
-
35
-
-
0033981670
-
Therapy of inflammatory bowel disease
-
Sands BE. Therapy of inflammatory bowel disease. Gastroenterology 2000; 118: S68-82.
-
(2000)
Gastroenterology
, vol.118
-
-
Sands, B.E.1
-
36
-
-
15644376138
-
Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats
-
Natsui M, Kawasaki K, Takizawa H etal. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J. Gastroenterol. Hepatol. 1997; 12: 801-8.
-
(1997)
J. Gastroenterol. Hepatol.
, vol.12
, pp. 801-808
-
-
Natsui, M.1
Kawasaki, K.2
Takizawa, H.3
-
37
-
-
0026748627
-
Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease
-
Simmonds NJ, Allen RE, Stevens TR, Van Someren RN, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992; 103: 186-96.
-
(1992)
Gastroenterology
, vol.103
, pp. 186-196
-
-
Simmonds, N.J.1
Allen, R.E.2
Stevens, T.R.3
Van Someren, R.N.4
Blake, D.R.5
Rampton, D.S.6
-
38
-
-
0028948704
-
Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis
-
Bhaskar L, Ramakrishna BS, Balasubramanian KA. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J. Gastroenterol. Hepatol. 1995; 10: 140-3.
-
(1995)
J. Gastroenterol. Hepatol.
, vol.10
, pp. 140-143
-
-
Bhaskar, L.1
Ramakrishna, B.S.2
Balasubramanian, K.A.3
-
40
-
-
0019132401
-
Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis
-
Dickinson RJ, Varian SA, Axon AT, Cooke EM. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut 1980; 21: 787-92.
-
(1980)
Gut
, vol.21
, pp. 787-792
-
-
Dickinson, R.J.1
Varian, S.A.2
Axon, A.T.3
Cooke, E.M.4
-
41
-
-
33645019411
-
Specificities of the fecal microbiota in inflammatory bowel disease
-
Sokol H, Seksik P, Rigottier-Gois L etal. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 2006; 12: 106-11.
-
(2006)
Inflamm. Bowel Dis.
, vol.12
, pp. 106-111
-
-
Sokol, H.1
Seksik, P.2
Rigottier-Gois, L.3
-
43
-
-
77951547991
-
Controlled release of protein from viable Lactococcus lactis cells
-
Stentz R, Bongaerts RJ, Gunning AP, Gasson M, Shearman C. Controlled release of protein from viable Lactococcus lactis cells. Appl. Environ. Microbiol. 2010; 76: 3026-31.
-
(2010)
Appl. Environ. Microbiol.
, vol.76
, pp. 3026-3031
-
-
Stentz, R.1
Bongaerts, R.J.2
Gunning, A.P.3
Gasson, M.4
Shearman, C.5
-
44
-
-
33745960395
-
The cationic host defense peptide rCRAMP promotes gastric ulcer healing in rats
-
Yang YH, Wu WK, Tai EK etal. The cationic host defense peptide rCRAMP promotes gastric ulcer healing in rats. J. Pharmacol. Exp. Ther. 2006; 318: 547-54.
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.318
, pp. 547-554
-
-
Yang, Y.H.1
Wu, W.K.2
Tai, E.K.3
-
45
-
-
0029063557
-
Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract
-
Klijn N, Weerkamp AH, de Vos WM. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 1995; 61: 2771-4.
-
(1995)
Appl. Environ. Microbiol.
, vol.61
, pp. 2771-2774
-
-
Klijn, N.1
Weerkamp, A.H.2
de Vos, W.M.3
|